aminolevulinic acid has been researched along with Peripheral Arterial Disease in 1 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Currently, efficient regimens to reverse atherosclerotic plaques are not available in the clinic." | 1.51 | Rapid inhibition of atherosclerotic plaque progression by sonodynamic therapy. ( Cao, W; Cao, Z; Chen, X; Cheng, J; Gao, W; Guo, S; Jiang, Y; Li, B; Li, M; Li, Q; Li, X; Li, Z; Peng, C; Shen, J; Sun, J; Sun, X; Tian, F; Tian, Y; Tian, Z; Wang, H; Wang, P; Wang, T; Wang, W; Wang, Y; Yang, J; Yang, Y; Yao, J; Zhang, Z; Zhao, X; Zhou, Q, 2019) |
| "The shrunken atherosclerotic plaques displayed compositional alterations, with a reduction in lesional macrophages and lipids." | 1.51 | Rapid inhibition of atherosclerotic plaque progression by sonodynamic therapy. ( Cao, W; Cao, Z; Chen, X; Cheng, J; Gao, W; Guo, S; Jiang, Y; Li, B; Li, M; Li, Q; Li, X; Li, Z; Peng, C; Shen, J; Sun, J; Sun, X; Tian, F; Tian, Y; Tian, Z; Wang, H; Wang, P; Wang, T; Wang, W; Wang, Y; Yang, J; Yang, Y; Yao, J; Zhang, Z; Zhao, X; Zhou, Q, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, X | 1 |
| Guo, S | 1 |
| Yao, J | 1 |
| Wang, H | 1 |
| Peng, C | 1 |
| Li, B | 1 |
| Wang, Y | 1 |
| Jiang, Y | 1 |
| Wang, T | 1 |
| Yang, Y | 1 |
| Cheng, J | 1 |
| Wang, W | 1 |
| Cao, Z | 1 |
| Zhao, X | 1 |
| Li, X | 1 |
| Sun, J | 1 |
| Yang, J | 1 |
| Tian, F | 1 |
| Chen, X | 1 |
| Li, Q | 1 |
| Gao, W | 1 |
| Shen, J | 1 |
| Zhou, Q | 1 |
| Wang, P | 1 |
| Li, Z | 1 |
| Tian, Z | 1 |
| Zhang, Z | 1 |
| Cao, W | 1 |
| Li, M | 1 |
| Tian, Y | 1 |
1 other study available for aminolevulinic acid and Peripheral Arterial Disease
| Article | Year |
|---|---|
Rapid inhibition of atherosclerotic plaque progression by sonodynamic therapy.
Topics: Aminolevulinic Acid; Animals; Aortic Diseases; Apoptosis; Atorvastatin; Carotid Artery Diseases; Cel | 2019 |